The Latest Clinical Articles in Psychiatry

1Evaluation of myo-Inositol as a potential biomarker for depression in schizophreniaNeuropsychopharmacology, March 27, 2015  Clinical Article
2Risperidone long-acting injection and one-year rehospitalization rate of schizophrenia patients: A retrospective cohort studyPsychiatry and Clinical Neurosciences, March 27, 2015  Clinical Article
3The impact of aerobic exercise on brain-derived neurotrophic factor and neurocognition in individuals with schizophrenia: A single-blind, randomized clinical trialSchizophrenia Bulletin, March 27, 2015  Clinical Article
4Depressive symptoms are associated with incident coronary heart disease or revascularization among Blacks but not among Whites in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) StudyAnnals of Epidemiology , March 27, 2015  Clinical Article
5Smoking is associated with acute and chronic prostatic inflammation: Results from the reduce studyCancer Prevention Research, March 27, 2015  Clinical Article
6Inhibition-based biomarkers for autism spectrum disorderNeurotherapeutics, March 27, 2015  Review Article
7Development and preliminary validation of a short form of the Beck Depression Inventory for Youth (BDI-Y) in a sample of adolescent cancer survivorsJournal of Cancer Survivorship, March 27, 2015  Clinical Article
8A prospective study on the use of teledermatology in psychiatric patients with chronic skin diseasesAustralasian Journal of Dermatology, March 27, 2015  Clinical Article
9Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: A review of current evidence and directions for future researchSchizophrenia Bulletin, March 27, 2015  Review Article
10Review of the evidence: Prevalence of medical conditions in the United States population with serious mental illnessGeneral Hospital Psychiatry, March 27, 2015  Review Article
1New NIMH strategic plan aims to focus, accelerate mental health researchNIH News, March 27, 2015
2American College of Physicians joins HHS in accelerating alternative payment methods through ‘Health Care Payment Learning and Action Network’ American College of Physicians News, March 26, 2015
3FDA Drug Safety Communication: FDA review of study sheds light on two deaths associated with the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate)FDA What's New: Drugs, March 25, 2015
4Researchers investigate antidepressant treatment for pain catastrophizingAmerican Society of Anesthesiologists News, March 23, 2015
5Brain networks differ among those with severe schizophrenia, CAMH study showsCentre for Addiction and Mental Health News, March 23, 2015
6Neuroscientists identify key cell type in the brain that controls body clock circadian rhythmsUT Southwestern Medical Center, March 19, 2015
7Childhood trauma linked to early psychosis later in lifeQueensland Brain Insitute News, March 19, 2015
8Repeated exposure of children to secondhand smoke is child abuse, Goldstein arguesUNC Health Care System, March 19, 2015
9Governments commit to advancements in dementia research and careWHO news, March 19, 2015
10Teen cannabis users have poor long-term memory in adulthoodNorthwestern Medicine News, March 17, 2015

Show Me:

Psychomotor speed predicts social function in schizophrenics

As reported in the Nordic Journal of Psychiatry, slow psychomotor speed predicts poor 5-y social function (OR=3.37) in patients with a diagnosis of schizophrenia spectrum. Global cognitive function and verbal learning ability had no association with subsequent social function.

Salivary markers for alcohol dependence identified

As reported in Alcohol & Alcoholism, salivary levels of α-fucosidase, β-glucuronidase, and α-mannosidase are elevated (7-18-fold) in patients with alcohol dependence compared to healthy controls.

Children’s Depression Screener is a useful tool

As reported in Psychiatry Research, the Children’s Depression Screener (ChilD-S) has been shown to have a diagnostic accuracy of 0.97 in children with depression and at a cut-off level ≥ 12, the sensitivity and specificity are 0.91 and 0.81, respectively.

Are YOU the Smartest Doc in America?

The Smartest Doc from MDLinx keeps you current with a competitive edge, pitting colleagues against one other for the title of The Smartest Doc in America.

Take the Challenge

Clinical Pearls

Clinical Pearl from Smartest DocThe prophylactic efficacy of SSRIs is limited in preventing recurrence of depression.

Clinical Pearl from Smartest DocAmong patients with OCD, research suggests that cognitive bias modification is an effective intervention for reducing OC beliefs.

Clinical Pearl from Smartest DocDesacyl ghrelin is a functional inhibitor of ghrelin, a potent hunger-stimulating peptide.

Be Ready for Upcoming 2015 Board Exams!

Be prepared for board reviews with confidence with 1000s of board exam style questions. Prepare Here